S

Slingshot Biosciences

64 employees

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Hematology
Biotech
Image Cytometry
Cell Analysis
FACS
Life Sciences
Synthetic Biology
Flow Cytometry
CAR-T
Therapeutics
Cell Therapies
Cell Engineering
Medical

Date founded

2012

Funding rounds raised

Total raised

$23M

from 6 investors over 6 rounds

S

Slingshot Biosciences raised $11M on February 6, 2023

Investors: Anterra Capital, ARCH Venture Partners and Northpond Ventures

S

Slingshot Biosciences raised $23M on July 22, 2021

Investors: Anterra Capital, Northpond Ventures and ARCH Venture Partners

FAQ